EP0261233A4 - Immortalized virus-specific tissue cells. - Google Patents
Immortalized virus-specific tissue cells.Info
- Publication number
- EP0261233A4 EP0261233A4 EP19870903002 EP87903002A EP0261233A4 EP 0261233 A4 EP0261233 A4 EP 0261233A4 EP 19870903002 EP19870903002 EP 19870903002 EP 87903002 A EP87903002 A EP 87903002A EP 0261233 A4 EP0261233 A4 EP 0261233A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tissue cells
- specific tissue
- immortalized
- virus
- immortalized virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84675786A | 1986-04-01 | 1986-04-01 | |
US846757 | 1986-04-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0261233A1 EP0261233A1 (en) | 1988-03-30 |
EP0261233A4 true EP0261233A4 (en) | 1988-08-29 |
Family
ID=25298865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19870903002 Withdrawn EP0261233A4 (en) | 1986-04-01 | 1987-04-01 | Immortalized virus-specific tissue cells. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0261233A4 (en) |
JP (1) | JPS63502962A (en) |
AU (1) | AU613310B2 (en) |
WO (1) | WO1987005930A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5218099A (en) * | 1986-04-01 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Post-transfusion, non-A, non-B hepatitis virus polynucleotides |
US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
US5698390A (en) | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
CN1049686C (en) * | 1987-11-18 | 2000-02-23 | 希龙股份有限公司 | Nanbv diagnostics and vaccines |
US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
JPH04501203A (en) * | 1988-07-06 | 1992-03-05 | ジェネラブズ インコーポレイティド | Post-transfusion-borne, non-A, non-B hepatitis viruses and antigens |
EP0460056A4 (en) * | 1989-02-24 | 1992-06-24 | Southwest Foundation For Biomedical Research | Non-a, non-b hepatitis hepatocyte cell culture |
US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
DE69031791T2 (en) * | 1989-08-25 | 1998-04-02 | Chiron Corp | Process for HCV cultivation in cell lines from B or T lymphocytes |
CA2079677A1 (en) * | 1990-04-03 | 1991-10-04 | Kenneth H. Burk | Purified hcv and hcv proteins and peptides |
EP1018558A3 (en) * | 1990-04-06 | 2002-06-05 | Genelabs Technologies, Inc. | Hepatitis C Virus Epitopes |
WO1994025064A1 (en) * | 1993-05-04 | 1994-11-10 | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES | Hepatitis c virus cell propagation and related methods |
WO1996024662A1 (en) * | 1995-02-10 | 1996-08-15 | Consiglio Nazionale Delle Ricerche | Process to 'in vitro' propagate the hepatitis c virus (hcv) in non lymphoblastoid animal cell cultures and products thereof |
GB201119011D0 (en) * | 2011-11-03 | 2011-12-14 | Queen Mary Innovation Ltd | Method |
WO2023239928A1 (en) * | 2022-06-09 | 2023-12-14 | CHO Plus Inc. | Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987001131A1 (en) * | 1985-08-19 | 1987-02-26 | Gene Labs, Inc. | Non-human primate monoclonal antibodies and methods |
WO1987005929A1 (en) * | 1986-04-01 | 1987-10-08 | Genelabs Incorporated | Immortalized cells which produce tissue-specific products |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4040905A (en) * | 1971-10-27 | 1977-08-09 | The United States Government | Sub-human primate diploid cell lines as substrates for virus vaccine production |
US4164566A (en) * | 1978-08-17 | 1979-08-14 | Merck & Co., Inc. | Hepatitis a virus cell culture in vitro |
US4395395A (en) * | 1979-05-21 | 1983-07-26 | The United States Of America As Represented By The Department Of Health And Human Services | Detection of non-A, non-B hepatitis associated antigen |
US4491632A (en) * | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
US4464474A (en) * | 1980-07-09 | 1984-08-07 | Connaught Laboratories Limited | Non-A, non-B hepatitis assay and vaccine |
US4621053A (en) * | 1980-07-30 | 1986-11-04 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Process for the production of human peptide hormones |
US4542016A (en) * | 1981-03-27 | 1985-09-17 | Institut Merieux | Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
CH652145A5 (en) * | 1982-01-22 | 1985-10-31 | Sandoz Ag | METHOD FOR IN VITRO PRODUCTION OF HYBRID OMEN WHAT human monoclonal antibodies GENERATE. |
US4438098A (en) * | 1982-01-27 | 1984-03-20 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Heat treatment of a non-A, non-B hepatitis agent to prepare a vaccine |
US4574116A (en) * | 1983-01-13 | 1986-03-04 | The Board Of Trustees Of The Leland Stanford Jr. University | Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes |
US4574166A (en) * | 1983-02-04 | 1986-03-04 | At&T Bell Laboratories | Tandem adaptive filter arrangement |
FR2545100B1 (en) * | 1983-04-29 | 1985-12-20 | Inst Nat Sante Rech Med | PROCESS FOR OBTAINING CULTURES OF HUMAN HEPATOCYTES, THE CULTURES OBTAINED AND THEIR BIOLOGICAL AND BIOCHEMICAL APPLICATIONS |
US4634666A (en) * | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
FR2565995B1 (en) * | 1984-03-07 | 1987-10-23 | Centre Nat Rech Scient | HYBRID CELLS PRODUCING A DETERMINED POLYPEPTIDE AND OBTAINED FROM PRIMARY CELLS NATURALLY CAPABLE OF EXPRESSING THIS POLYPEPTIDE OR AN EQUIVALENT POLYPEPTIDE, PROCESS FOR OBTAINING SUCH HYBRID CELLS, AND APPLICATION THEREOF TO THE PRODUCTION THEREOF |
-
1987
- 1987-04-01 JP JP62502304A patent/JPS63502962A/en active Pending
- 1987-04-01 AU AU72383/87A patent/AU613310B2/en not_active Ceased
- 1987-04-01 EP EP19870903002 patent/EP0261233A4/en not_active Withdrawn
- 1987-04-01 WO PCT/US1987/000711 patent/WO1987005930A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987001131A1 (en) * | 1985-08-19 | 1987-02-26 | Gene Labs, Inc. | Non-human primate monoclonal antibodies and methods |
WO1987005929A1 (en) * | 1986-04-01 | 1987-10-08 | Genelabs Incorporated | Immortalized cells which produce tissue-specific products |
Non-Patent Citations (1)
Title |
---|
See also references of WO8705930A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0261233A1 (en) | 1988-03-30 |
WO1987005930A1 (en) | 1987-10-08 |
JPS63502962A (en) | 1988-11-02 |
AU7238387A (en) | 1987-10-20 |
AU613310B2 (en) | 1991-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2191332B (en) | Electrochemical cell | |
GB2200639B (en) | Acellular red blood cell substitute | |
ZA871695B (en) | Membrane | |
EP0261233A4 (en) | Immortalized virus-specific tissue cells. | |
GB2187590B (en) | Electrochemical cells | |
GB2191333B (en) | Electrochemical cell | |
GB2192305B (en) | Electrochemical cell | |
GB8606479D0 (en) | Incubator | |
GB8613798D0 (en) | Electrolyte | |
EP0237941A3 (en) | Incubator | |
GB8726423D0 (en) | Membrane keyboard | |
GB8706406D0 (en) | Mediators for bio-electrochemical cells | |
GB8608053D0 (en) | Membrane | |
GB8711693D0 (en) | Membrane keyboard | |
GB8709639D0 (en) | Electrochemical cells | |
ZA875899B (en) | Electrochemical cell | |
PT85828A (en) | Cell transfection | |
GB8725065D0 (en) | Membrane | |
EP0271085A3 (en) | Deferred-action cell | |
GB8717796D0 (en) | Donor sheet | |
GB8611131D0 (en) | Cells | |
SU1374711A1 (en) | Solid electrolyte | |
GB8624438D0 (en) | Electrolytoc cell | |
GB8612651D0 (en) | Cell culture | |
GB2196171B (en) | Electrochemical cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19871202 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19880829 |
|
17Q | First examination report despatched |
Effective date: 19910307 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19921013 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: RABIN, LINDA, B. Inventor name: FOUNG, STEVEN, K., H. |